European Commission grants conditional approval for Abbott's $25B St. Jude Medical acquisition

The European Commission granted conditional approval for Abbott's $25 billion acquisition of St. Jude Medical, requiring the divestiture of St. Jude's Angio-Seal and Femoseal vascular closure assets and Abbott's Vado steerable sheath, which are already slated for sale to Terumo for $1 billion.

“Anti-trust regulators in the European Union last week granted conditional approval for the $25 billion merger of Abbott and St. Jude Medical.”massdevice.com

• 3 sources
• massdevice.comEuropean anti-trust regulators grant conditional approval for Abbott's $25B St. Jude Medical buy - MassDeviceBrad PerrielloNov 28, 2016
• abbott.mediaroom.comAbbott Completes the Acquisition of St. Jude MedicalJan 4, 2017
• massdevice.comAbbott closes $25B St. Jude buy - MassDeviceFink DensfordJan 4, 2017

Summarized from public sources; check the original articles before acting on it.